Research Analysts Offer Predictions for TriMas Q2 Earnings

TriMas Corporation (NASDAQ:TRS) – Analysts at Zacks Research dropped their Q2 2027 earnings estimates for TriMas in a report released on Wednesday, July 22nd. Zacks Research analyst Team now anticipates that the industrial products company will post earnings of $0.58 per share for the quarter, down from their previous forecast of $0.62. Zacks Research currently has a “Hold” rating on the stock. The consensus estimate for TriMas’ current full-year earnings is $1.67 per share. Zacks Research also issued estimates for TriMas’ Q4 2027 earnings at $0.50 EPS and Q2 2028 earnings at $0.57 EPS.

Separately, Weiss Ratings upgraded shares of TriMas from a “buy (b-)” rating to a “buy (b)” rating in a report on Tuesday, June 23rd. Three analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $41.50.

TriMas Stock Down 0.5%

TRS stock opened at $40.03 on Friday. TriMas has a twelve month low of $30.43 and a twelve month high of $45.42. The company has a quick ratio of 4.50, a current ratio of 4.85 and a debt-to-equity ratio of 0.27. The firm has a market cap of $1.43 billion, a PE ratio of 1.66 and a beta of 0.59. The business has a 50 day moving average of $41.20 and a 200 day moving average of $38.25.

TriMas (NASDAQ:TRS) last released its earnings results on Thursday, April 30th. The industrial products company reported $0.24 EPS for the quarter, missing analysts’ consensus estimates of $0.48 by ($0.24). TriMas had a net margin of 93.79% and a return on equity of 8.38%. The firm had revenue of $168.28 million during the quarter, compared to analysts’ expectations of $158.24 million. During the same quarter in the previous year, the business earned $0.46 EPS. The company’s revenue for the quarter was up 10.3% compared to the same quarter last year. TriMas has set its FY 2026 guidance at 1.500-1.70 EPS.

TriMas Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, August 13th. Shareholders of record on Thursday, August 6th will be issued a $0.04 dividend. The ex-dividend date is Thursday, August 6th. This represents a $0.16 dividend on an annualized basis and a yield of 0.4%. TriMas’s dividend payout ratio (DPR) is presently 0.66%.

Insider Transactions at TriMas

In other TriMas news, Director Herbert K. Parker sold 15,000 shares of TriMas stock in a transaction on Tuesday, June 30th. The shares were sold at an average price of $45.03, for a total transaction of $675,450.00. Following the sale, the director owned 57,762 shares of the company’s stock, valued at $2,601,022.86. The trade was a 20.62% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 17.50% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of TRS. Bank of America Corp DE raised its stake in TriMas by 1.7% in the 1st quarter. Bank of America Corp DE now owns 3,845,726 shares of the industrial products company’s stock valued at $138,215,000 after purchasing an additional 62,802 shares during the last quarter. Quantinno Capital Management LP boosted its holdings in shares of TriMas by 10.4% during the first quarter. Quantinno Capital Management LP now owns 14,303 shares of the industrial products company’s stock worth $514,000 after purchasing an additional 1,345 shares during the last quarter. Lazard Asset Management LLC grew its position in shares of TriMas by 43.5% in the first quarter. Lazard Asset Management LLC now owns 157,984 shares of the industrial products company’s stock valued at $5,678,000 after purchasing an additional 47,885 shares during the period. Punch & Associates Investment Management Inc. purchased a new stake in shares of TriMas in the first quarter valued at $8,795,000. Finally, Healthcare of Ontario Pension Plan Trust Fund acquired a new position in TriMas in the first quarter valued at $7,015,000. 99.42% of the stock is currently owned by institutional investors and hedge funds.

Key Stories Impacting TriMas

Here are the key news stories impacting TriMas this week:

• Positive Sentiment: Zacks Research raised its Q1 2027 EPS estimate for TriMas to $0.51 from $0.40, indicating improved expectations for near-term earnings power. TriMas stock page
• Neutral Sentiment: TriMas declared a quarterly dividend of $0.04 per share, payable August 13 to shareholders of record on August 6. The payout is small, with a modest yield of about 0.4%, so the announcement is unlikely to be a major driver of the stock. TriMas stock page
• Neutral Sentiment: TriMas is scheduled to report quarterly earnings soon, which may keep the stock active as investors look for confirmation of whether management can meet or beat the current full-year EPS consensus of $1.67. TriMas stock page
• Negative Sentiment: Zacks Research cut its Q2 2027 EPS estimate to $0.58 from $0.62, suggesting slightly weaker expectations for that period. TriMas stock page
• Negative Sentiment: The firm also reduced its Q3 2027 EPS estimate to $0.59 from $0.64 and its Q4 2027 estimate to $0.50 from $0.52, alongside a smaller trim to Q2 2028 EPS to $0.57 from $0.59. These downward revisions may pressure sentiment even though Zacks still rates the stock “Hold.” TriMas stock page

TriMas Company Profile

TriMas Corporation is a diversified industrial company headquartered in Bloomfield Hills, Michigan. Established in 1980, TriMas has built a global reputation for designing and manufacturing specialized products that serve a wide array of end markets. The company operates through multiple segments, each focused on high-demand niches where engineered solutions and rigorous quality standards are essential.

The Packaging segment supplies closures, dispensing systems and related components for the personal care, household chemicals, food and beverage, and pharmaceutical markets.